[Role of Cancer Chemotherapy Is Expected to Improve PS and QOL].
We report three cases of advanced lung cancer with poor PS treated with molecular-targeted drugs and consider the role of cancer chemotherapy to improve quality of life(QOL). Case 1: A 67-year-old woman(PS 3)with multiple liver, bone, and lymph node metastases from lung cancer received gefitinib and radiation therapy for bone metastasis. Abdominal CT then showed shrinkage of the liver metastasis, and daily life activities became possible after 2 months. Case 2: A 76-year-old woman with SVC syndrome from Stage ⅢA of lung cancer received gefitinib and radiation therapy. After that, edema and cough disappeared, and the PS improved from 3 to 0. Case 3: A 41-year-old woman with pleural dissemination from Stage Ⅳ lung cancer received ALK inhibitors and anticancer drug therapy for 5 years. Subsequently, a decrease in QOL was noted due to symptoms such as bloody sputum and persistence of cough. ALK inhibitors were administered as a re-challenge. A dramatic improvement in symptoms was observed in a few days. Even if the general condition is poor, PS can be improved by administering drugs such as molecular-targeted drugs.